Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71:209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Kalager M, Haldorsen T, Bretthauer M, Hoff G, Thoresen SO, Adami HO (2009) Open access improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 11:44. https://doi.org/10.1186/bcr2331

Article  Google Scholar 

Berry DA, Cronin KA, Plevritis SK, et al. ( 2005) Effect of screening and adjuvant therapy on mortality from breast cancer for the cancer intervention and surveillance modeling network (CISNET) Collaborators, vol 17. http://cisnet.cancer.gov/

Elmore JG, Reisch LM, Barton MB et al (2005) Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 97(14):1035–1043. https://doi.org/10.1093/jnci/dji183

Article  PubMed  Google Scholar 

Abe O, Abe R, Enomoto K et al (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717. https://doi.org/10.1016/S0140-6736(05)66544-0

Article  CAS  Google Scholar 

Wapnir IL, Anderson SJ, Mamounas EP et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol 24(13):2028–2037. https://doi.org/10.1200/JCO.2005.04.3273

Article  PubMed  Google Scholar 

Anderson SJ, Wapnir I, Dignam JJ et al (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 27(15):2466–2473. https://doi.org/10.1200/JCO.2008.19.8424

Article  PubMed  PubMed Central  Google Scholar 

Piccart-Gebhart MJ, Procter M, Sci M, et al. (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med.:353. www.nejm.org. Accessed 6 Sept 2022

Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ (2012) Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat 133(3):831–841. https://doi.org/10.1007/s10549-011-1891-6

Article  PubMed  Google Scholar 

Yang SH, Yang KH, Li YP et al (2008) Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol 19(6):1039–1044. https://doi.org/10.1093/annonc/mdm573

Article  CAS  PubMed  Google Scholar 

Adra J, Lundstedt D, Killander F et al (2019) Distribution of locoregional breast cancer recurrence in relation to postoperative radiation fields and biological subtypes. Int J Radiat Oncol Biol Phys 105(2):285–295. https://doi.org/10.1016/j.ijrobp.2019.06.013

Article  PubMed  Google Scholar 

Valachis A, Mamounas EP, Mittendorf EA et al (2018) Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: an international collaboration and individual patient meta-analysis. Cancer. https://doi.org/10.1002/cncr.31518

Article  PubMed  Google Scholar 

Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. https://academic.oup.com/jnci/article/92/14/1143/2905865

Arriagada R, Lê MG, Guinebretière JM, Dunant A, Rochard F, Tursz T (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14(11):1617–1622. https://doi.org/10.1093/annonc/mdg452

Article  CAS  PubMed  Google Scholar 

Mberto U, Eronesi V, Atale N, et al. (2002) The New England journal of medicine twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer abstract background we conducted 20 years of follow-up, vol 347. www.nejm.org

Wang J, Wang S, Tang Y et al (2018) Comparison of treatment outcomes with breast-conserving surgery plus radiotherapy versus mastectomy for patients with stage I breast cancer: a propensity score-matched analysis. Clin Breast Cancer 18(5):e975–e984. https://doi.org/10.1016/j.clbc.2018.06.002

Article  PubMed  Google Scholar 

Corradini S, Reitz D, Pazos M et al (2019) Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases. Cancers (Basel). 11(2):160. https://doi.org/10.3390/cancers11020160

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou X, Li Y (2016) Local recurrence after breast-conserving surgery and mastectomy following neoadjuvant chemotherapy for locally advanced breast cancer-a meta-analysis. Breast Care 11(5):345–351. https://doi.org/10.1159/000450626

Article  PubMed  PubMed Central  Google Scholar 

van Maaren MC, de Munck L, Jobsen JJ et al (2016) Breast-conserving therapy versus mastectomy in T1–2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients. Breast Cancer Res Treat 160(3):511–521. https://doi.org/10.1007/s10549-016-4012-8

Article  CAS  PubMed  Google Scholar 

Chen K, Liu J, Zhu L, Su F, Song E, Jacobs LK (2015) Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: a NCDB analysis, vol 6. www.impactjournals.com/oncotarget/

Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res 13(15):4429–4434. https://doi.org/10.1158/1078-0432.CCR-06-3045

Article  PubMed  Google Scholar 

Billar JAY, Dueck AC, Stucky CCH et al (2010) Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol 17:384–390. https://doi.org/10.1245/s10434-010-1260-4

Article  PubMed  Google Scholar 

Voduc KD, Cheang MCU, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28(10):1684–1691. https://doi.org/10.1200/JCO.2009.24.9284

Article  PubMed  Google Scholar 

Millar EKA, Graham PH, O’Toole SA et al (2009) Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27(28):4701–4708. https://doi.org/10.1200/JCO.2008.21.7075

Article  PubMed  Google Scholar 

Arvold ND, Taghian AG, Niemierko A et al (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29(29):3885–3891. https://doi.org/10.1200/JCO.2011.36.1105

Article  PubMed  PubMed Central  Google Scholar 

O’Brien KM, Cole SR, Tse CK et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the carolina breast cancer study. Clin Cancer Res 16(24):6100–6110. https://doi.org/10.1158/1078-0432.CCR-10-1533

Article  PubMed  PubMed Central  Google Scholar 

Sørlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. https://doi.org/10.1073/pnas.191367098

Article  PubMed  PubMed Central  Google Scholar 

McGuire A, Lowery AJ, Kell MR, Kerin MJ, Sweeney KJ (2017) Locoregional recurrence following breast cancer surgery in the trastuzumab era: a systematic review by subtype. Ann Surg Oncol 24(11):3124–3132. https://doi.org/10.1245/s10434-017-6021-1

Article  PubMed  Google Scholar 

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 235(4785):177–182. https://doi.org/10.1126/science.3798106

Article  CAS  PubMed  Google Scholar 

Fodor A, Brombin C, Mangili P et al (2021) Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: should the indications for radiotherapy be more personalized? Breast 55:45–54. https://doi.org/10.1016/j.breast.2020.12.004

Article  PubMed  Google Scholar 

Sanpaolo P, Barbieri V, Genovesi D (2011) Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Eur J Surg Oncol 37(10):876–882. https://doi.org/10.1016/j.ejso.2011.07.001

Article  CAS  PubMed  Google Scholar 

Magnoni F, Corso G, Maisonneuve P et al (2023) A propensity score–matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer. J Cancer Res Clin Oncol 149(3):1085–1093. https://doi.org/10.1007/s00432-022-03973-8

Article  PubMed  Google Scholar 

Hou J, Zhou Z, Chen X, et al. (2016) HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo, vol 7. www.impactjournals.com/oncotarget

Soerjomataram I, Louwman MWJ, Ribot JG, Roukema JA, Coebergh JWW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107(3):309–330. https://doi.org/10.1007/s10549-007-9556-1

Article  CAS  PubMed  Google Scholar 

Rueda OM, Sammut SJ, Seoane JA et al (2019) Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups. Nature 567(7748):399–404. https://doi.org/10.1038/s41586-019-1007-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burstein HJ, Temin S, Anderson H et al (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. J Clin Oncol 32(21):2255–2269. https://doi.org/10.1200/JCO.2013.54.2258

Article  PubMed  PubMed Central  Google Scholar 

Pan H, Gray R, Braybrooke J et al (2017) 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med 377(19):1836–1846. https://doi.org/10.1056/nejmoa1701830

Article  PubMed  PubMed Central  Google Scholar 

Wapnir IL, Price KN, Anderson SJ et al (2018) Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial. J Clin Oncol 36(11):1073–1079. https://doi.org/10.1200/JCO.2017.76.5719

Article